TY - JOUR
T1 - Convergent genetic and expression data implicate immunity in Alzheimer's disease
AU - International Genomics of Alzheimer's Disease Consortium (IGAP)
AU - Jones, Lesley
AU - Lambert, Jean Charles
AU - Wang, Li San
AU - Choi, Seung Hoan
AU - Harold, Denise
AU - Vedernikov, Alexey
AU - Escott-Price, Valentina
AU - Stone, Timothy
AU - Richards, Alexander
AU - Bellenguez, Céline
AU - Ibrahim-Verbaas, Carla A.
AU - Naj, Adam C.
AU - Sims, Rebecca
AU - Gerrish, Amy
AU - Jun, Gyungah
AU - DeStefano, Anita L.
AU - Bis, Joshua C.
AU - Beecham, Gary W.
AU - Grenier-Boley, Benjamin
AU - Russo, Giancarlo
AU - Thornton-Wells, Tricia A.
AU - Jones, Nicola
AU - Smith, Albert V.
AU - Chouraki, Vincent
AU - Thomas, Charlene
AU - Ikram, M. Arfan
AU - Zelenika, Diana
AU - Vardarajan, Badri N.
AU - Kamatani, Yoichiro
AU - Lin, Chiao Feng
AU - Schmidt, Helena
AU - Kunkle, Brian W.
AU - Dunstan, Melanie L.
AU - Ruiz, Agustin
AU - Bihoreau, Marie Thérèse
AU - Reitz, Christiane
AU - Pasquier, Florence
AU - Hollingworth, Paul
AU - Hanon, Olivier
AU - Fitzpatrick, Annette L.
AU - Buxbaum, Joseph D.
AU - Campion, Dominique
AU - Crane, Paul K.
AU - Becker, Tim
AU - Gudnason, Vilmundur
AU - Cruchaga, Carlos
AU - Craig, David
AU - Amin, Najaf
AU - Berr, Claudine
AU - Seshadri, Sudha
N1 - Publisher Copyright:
© 2015, Elsevier Inc. All rights reserved.
PY - 2015/6/1
Y1 - 2015/6/1
N2 - Background: Late-onset Alzheimer's disease (AD) is heritable with 20 genes showing genome-wide association in the International Genomics of Alzheimer's Project (IGAP). To identify the biology underlying the disease, we extended these genetic data in a pathway analysis. Methods: The ALIGATOR and GSEA algorithms were used in the IGAP data to identify associated functional pathways and correlated gene expression networks in human brain. Results: ALIGATOR identified an excess of curated biological pathways showing enrichment of association. Enriched areas of biology included the immune response (P = 3.27 × 10-12 after multiple testing correction for pathways), regulation of endocytosis (P = 1.31 × 10-11), cholesterol transport (P = 2.96 × 10-9), and proteasome-ubiquitin activity (P = 1.34 × 10-6). Correlated gene expression analysis identified four significant network modules, all related to the immune response (corrected P =.002-.05). Conclusions: The immune response, regulation of endocytosis, cholesterol transport, and protein ubiquitination represent prime targets for AD therapeutics.
AB - Background: Late-onset Alzheimer's disease (AD) is heritable with 20 genes showing genome-wide association in the International Genomics of Alzheimer's Project (IGAP). To identify the biology underlying the disease, we extended these genetic data in a pathway analysis. Methods: The ALIGATOR and GSEA algorithms were used in the IGAP data to identify associated functional pathways and correlated gene expression networks in human brain. Results: ALIGATOR identified an excess of curated biological pathways showing enrichment of association. Enriched areas of biology included the immune response (P = 3.27 × 10-12 after multiple testing correction for pathways), regulation of endocytosis (P = 1.31 × 10-11), cholesterol transport (P = 2.96 × 10-9), and proteasome-ubiquitin activity (P = 1.34 × 10-6). Correlated gene expression analysis identified four significant network modules, all related to the immune response (corrected P =.002-.05). Conclusions: The immune response, regulation of endocytosis, cholesterol transport, and protein ubiquitination represent prime targets for AD therapeutics.
KW - ALIGATOR
KW - Alzheimer's disease
KW - Cholesterol metabolism
KW - Dementia
KW - Endocytosis
KW - Immune response
KW - Neurodegeneration
KW - Pathway analysis
KW - Ubiquitination
KW - Weighted gene co-expression network analysis
UR - http://www.scopus.com/inward/record.url?scp=84931560814&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84931560814&partnerID=8YFLogxK
U2 - 10.1016/j.jalz.2014.05.1757
DO - 10.1016/j.jalz.2014.05.1757
M3 - Article
C2 - 25533204
AN - SCOPUS:84931560814
SN - 1552-5260
VL - 11
SP - 658
EP - 671
JO - Alzheimer's and Dementia
JF - Alzheimer's and Dementia
IS - 6
ER -